PRDX1 and breast carcinoma: It was also found that drug resistance formation is accompanied by a significant increase in the expression of PRDX1 gene in breast cancer cell strains, which confirms the important contribution of redox‐dependent mechanisms to the development of cisplatin resistance of cancer cells 56.